Cleared Traditional

K211346 - BLUE 400 (FDA 510(k) Clearance)

Jul 2022
Decision
445d
Days
Class 2
Risk

K211346 is an FDA 510(k) clearance for the BLUE 400. This device is classified as a Diagnostic Neurosurgical Microscope Filter (Class II - Special Controls, product code QFX).

Submitted by Carl Zeiss Meditec, AG (Jena, DE). The FDA issued a Cleared decision on July 22, 2022, 445 days after receiving the submission on May 3, 2021.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.4950. A Diagnostic Neurosurgical Microscope Filter Is A Device Intended For Use During Neurosurgery To Visualize Fluorescence And Enhance Visualization Of Tissue Associated With A Specific Disease Or Condition..

Submission Details

510(k) Number K211346 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 03, 2021
Decision Date July 22, 2022
Days to Decision 445 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code QFX — Diagnostic Neurosurgical Microscope Filter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.4950
Definition A Diagnostic Neurosurgical Microscope Filter Is A Device Intended For Use During Neurosurgery To Visualize Fluorescence And Enhance Visualization Of Tissue Associated With A Specific Disease Or Condition.